Mel Bridges

Melvyn John Bridges founded ImpediMed Ltd. in 1999, where he worked as Independent Non-Executive Director from 2011 to 2013.
Dr. Bridges also founded Catapult Genetics Pty Ltd., Peptech Animal Health Pty Limited, Abbott Rapid Diagnostics Pty Ltd., where he worked as Chief Executive Officer, and Pacific Diagnostics, where he worked as Managing Director.
Dr. Bridges also currently works at IMBcom Pty Ltd., as Director.
Dr. Bridges also formerly worked at Gtech International Resources Ltd., as Chairman & Chief Executive Officer from 2011 to 2012, Anatara Lifesciences Ltd., as Executive Chairman & Chief Executive Officer from 2016 to 2018, Genetic Technologies Ltd., as Non-Executive Chairman in 2012, The Sustainable Nutrition Group Pty Ltd., as Executive Chairman in 2013, Incitive Ltd., as Executive Chairman from 2007 to 2010, Arana Therapeutics Ltd., as Chairman from 2002 to 2007, AquaCarotene Ltd., as Chairman in 2010, Genetic Solutions Pty Ltd., as Chairman, DelvTech International Pty Ltd., as Chairman, Cleveland Biosensors Pty Ltd., as Chairman, Farmacule BioIndustries Pty Ltd., as Chairman, Foresta Group Holdings Ltd., as Executive Chairman from 2011 to 2012, Quintek Technologies, Inc., as Managing Director, Dominion Minerals Ltd., as Independent Non-Executive Director from 2012 to 2015, ALS Ltd., as Independent Non-Executive Director, Benitec Biopharma Ltd., as Independent Non-Executive Director from 2013 to 2014, Genera Biosystems Ltd., as Non-Executive Director from 2008 to 2010, and Oventus Medical Ltd., as Non-Executive Director from 2020 to 2023.
Dr. Bridges received his undergraduate degree from Queensland University of Technology.